Comment on: A systematic review of patient-reported outcome measures in patients with ANCA-associated vasculitis: reply
Authors:
- 6 April 2026
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (4)
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitisRheumatology, 2024
- Guidance to best tools and practices for systematic reviewsSystematic Reviews, 2023
- Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-AnalysisValue in Health, 2022
- Enhancing the multi-dimensional assessment of quality of life: introducing the WHOQOL-CombiQuality of Life Research, 2020
- Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaireAnnals of the Rheumatic Diseases, 2018
- The development of a financial toxicity patient‐reported outcome in cancer: The COST measureCancer, 2014
- Wegener's granulomatosis: Patient-reported effects of disease on health, function, and incomeArthritis & Rheumatism, 1998
- Development of the World Health Organization WHOQOL-BREF Quality of Life AssessmentPsychological Medicine, 1998